A new randomized controlled trial tested whether adding a ketogenic diet to GLP-1 medication improves outcomes in type 2 diabetes.Researchers took 104 patients with type 2 diabetes. Half received the GLP-1 agonist dulaglutide alone, while the other half combined it with a ketogenic diet.The combination group outperformed medication alone in lowering blood glucose and lipid levels, with a statistically significant drop in insulin resistance and a boost in insulin sensitivity. At the six-month mar